Lab Services
Your trusted partner in pharmacology and pharmacokinetics lab services.
At Xyzagen, our Lab Services support early drug discovery and development by delivering high-quality nonGLP bioanalytical services, in vitro ADME, discovery genomics, CMC, and in vivo PK through our First-in-Rodent solutions. Backed by technology and experience, our scientists ensure timely and precise data generation to drive confident decisions across your nonclinical and clinical programs.
How We Support
Your Program
As a discovery-focused organization, Xyzagen offers more than lab testing—we act as an extension of your R&D team. Our scientists work across disciplines to support your early development programs, integrating pharmacology, pharmacokinetics, genomics, and regulatory strategy to streamline progression toward IND and beyond.
Why Choose Xyzagen for Lab Services?
Xyzagen combines deep scientific expertise with a fully functioning research lab to deliver reliable, discovery-aligned lab support across discovery support and late stage development.
With decades of scientific experience and integrated support from discovery to clinical, Xyzagen’s lab services are designed to accelerate decision-making with accuracy, speed, and strategic alignment.
The Xyzagen
Difference
Regulatory Support
Deep knowledge of regulations and GLP-compliant required services tailored for your IND and NDA submission
Integrated Model
Lab services directly support our clinical pharmacology, regulatory, and modeling teams
Experienced Team
Scientists with decades of bioanalytical, ADME, and PK program experience
Flexible and Collaborative
Customizable workflows that scale with your program’s needs
Our Core Lab Service Offerings
Bioanalytical Services
Bioanalysis is the foundation of pharmacokinetic (PK), toxicokinetic (TK), and biomarker studies. Our LC-MS/MS and ligand-binding capabilities provide pharmacologically relevant sensitive and selective quantitation of drugs, metabolites, and biomarkers in diverse biological matrices.
ADME Studies
Understanding a drug’s ADME is critical for optimizing and identifying lead Pre-IND enabled compounds for GLP toxicology and safety. Our suite of ADME studies characterize metabolic pathways, plasma protein binding, and permeability—and can augment PBPK models with in vitro data clients may not already have.
Genomics & Biomarker Analysis
Our discovery genomics services help in the PGx translational research of your program. From gene expression profiling to qPCR-based gene quantification, we provide molecular insights that support target validation and mechanism-of-action studies in our First-in-Rodent program.
Formulation & Analytical Testing
We support early nonclinical and discovery studies by ensuring compound integrity, purity, and stability. We provide solubility assessment, stability testing, and early formulation screening to complement pharmacology, PK/PD, and toxicology studies within our First-in-Rodent portfolio.
Additional Lab-Related Capabilities
Nonclinical Program Management
With over 30 years of drug discovery experience, we bring deep relationships across the CRO landscape to help manage your program through IND. Whether it’s engaging a toxicologist for study design or coordinating pathology review, we provide cost-effective oversight while streamlining program execution across pharmacology, PK, toxicology, and CMC.
Learn more about how we’ve successfully managed Ophthalmology and Neurology programs from discovery through IND.
Pharmacokinetic (PK) Kits
We create, ship, and manage PK sampling kits for small-scale clinical trials, ensuring smooth coordination between clinical operations and GLP bioanalytical labs. Our kits dovetail with the pharmacokinetic analysis of your clinical study and support sparse sampling strategies in Phase 2 and 3 trials—critical for enabling population PK and other regulatory modeling efforts.
Learn more about how sparse sampling in a Phase 2 or 3 trial can support your population PK goals.
In Vivo PK & Metabolism Studies
We offer robust in vivo pharmacokinetic (PK) and metabolism capabilities including our trademarked First-in-Rat™ and First-in-Mouse™ studies. Our services include dose solution analysis, metabolite profiling, and bioanalytical support for nonclinical PK studies. We run the rodent PK studies in house and have 3rd party vendors for large animal studies.
Contact Us
Get in touch today to discuss how our Lab Services can support your drug development program!
